{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-021464","form_type":"8-K","ticker":"SNWV","cik":"0001417663","company_name":"SANUWAVE Health, Inc.","filed_at":"2026-03-26T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.032440+00:00","generated_at":"2026-05-15T08:48:24.094075+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Sanuwave records Q4 revenue $13.4M (+29.7% YoY); FY rev $44.1M; guides FY26 $51-55M","bullets":["Q4 2025 revenue record $13.4M (+29.7% YoY); FY 2025 revenue record $44.1M (+35% YoY).","GAAP operating income $2.0M Q4 ($4.9M FY); net income $7.7M Q4 vs loss $13.3M Q4 2024.","Adjusted EBITDA Q4 $4.8M vs $3.7M YoY; FY $13.6M vs $7.2M YoY.","Guides Q1 2026 rev $9.6-10.3M (+3-10%); FY 2026 rev $51-55M (+16-25% vs FY25).","Sold 255 UltraMist systems in Q4 (up from 135); consumables rev +10.6% to $6.5M."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-021464","json":"https://secwatch.observer/filing/0001628280-26-021464.json","markdown":"https://secwatch.observer/filing/0001628280-26-021464.md","text":"https://secwatch.observer/filing/0001628280-26-021464.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1417663/000162828026021464/0001628280-26-021464-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1417663/000162828026021464/snwv-20260326.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T08:48:24.094075+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b844e18dca4069ec5bea014cbc0201fc745094df","claim":"SANUWAVE Health, Inc. reported the fourth quarter and fiscal year ended December 31, 2025 results: revenue $13.4 million, net income $7.7 million. Guidance initiated.","evidence_excerpt":"forth by specific reference in such filing. --- EX-99.1 (EX-99.1) --- Sanuwave Announces Record Revenues and Financial Results for Q4 and Full Year 2025 Q4 2025 revenues were $13.4 million, up 29.7% from Q4 2024. This was an all-time quarterly record for the Company. Full year 2025 revenues were $44.1 million up 35.0% from full year 2024 revenues. This was an","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1417663/000162828026021464/0001628280-26-021464-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter and fiscal year ended December 31, 2025"},{"label":"Revenue","value":"$13.4 million"},{"label":"Net income","value":"$7.7 million"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}